Day: July 1, 2020

LOS ANGELES, CALIFORNIA, July 01, 2020 (GLOBE NEWSWIRE) — GTX Corp (GTXO), a pioneer in the field of health and safety wearable technology and an Industry Wired top company to watch in 2020, is pleased to announce it is has begun selling masks and other Personal Protective Equipment “PPE” on Amazon.“As the coronavirus pandemic continues to ravage large swaths of the U.S., we are seeing a direct correlation in PPE demand on our online store and a surge in orders this past week. Going live on Amazon was the fasted way for us to help meet that demand and reach a larger audience now,” commented Meghan Ravada, GTX Corp Customer Relations Manager.“GTX Corp has delivered hundreds of thousands of PPE items to a wide range of entities such as essential businesses, assisted living facilities, pharmacies, Fortune 1,000 companies, hospitals,...

JASPER, Ind., July 01, 2020 (GLOBE NEWSWIRE) — German American Bancorp, Inc. (NASDAQ: GABC) has announced several pending changes to its executive management group as part of an ongoing management succession plan.  The Company’s Board of Directors, at its recent annual reorganization meeting, approved the following promotions effective as of January 1, 2021:  Clay W. Ewing will be assuming the newly created position of Vice Chairman, D. Neil Dauby will be assuming the position of President & Chief Operating Officer and Bradley M. Rust will assume the position of Senior Executive Vice President.Mr. Ewing, who has been with German American for the past 26 years and has over 41 years of banking industry experience, currently serves as the Company’s President & Chief Banking Officer.  Clay, who has served in various corporate...

First Quarter 2020 HighlightsTotal Net Revenue of $836,000Continuation of Sales & Marketing BuildoutRestructuring of Company and Board of DirectorsBegan Biomass Inventory Extraction ProcessDuring Q2 2020, The Company Received PPP Funds and an SBA LoanDELRAY BEACH, Fla., July 01, 2020 (GLOBE NEWSWIRE) — Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020.During the first quarter of 2020, Exactus is pleased it has reported record revenue as its investment into sales and marketing has begun to generate revenue and scale. The Company has significantly cut its monthly cash burn and has shifted its focus to rapidly generate revenue through bulk specialty ingredient sales. Moving into the second...

GLYFADA, Greece, July 01, 2020 (GLOBE NEWSWIRE) — Globus Maritime Limited (the “Company”) (NASDAQ: GLBS) announced that on June 30, 2020 it closed the previously announced registered direct offering and concurrent private placement of warrants. The gross proceeds to the Company from the registered direct offering and concurrent private placement were approximately $12.4 million before deducting the placement agent’s fees and other estimated offering expenses.About Globus Maritime LimitedGlobus is an integrated dry bulk shipping company that provides marine transportation services worldwide and presently owns, operates and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina and other dry bulk cargoes internationally. Globus’s subsidiaries own and operate 5 vessels with a total...

NEEDHAM, Mass., July 01, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its proprietary Transient Permeability Enhancer (TPE®) delivery platform technology to reduce the burden of chronic injections for people with rare diseases, today announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock and, to certain investors in lieu thereof, pre-funded warrants to purchase up to 5,000,000 shares of its common stock at an exercise price of $0.0001 per share. The public offering price of each share of common stock is $4.00 and the public offering price of each pre-funded warrant is $3.9999 per underlying share. In addition, Chiasma has granted the underwriters a 30-day...

SPARTANBURG, S.C., July 01, 2020 (GLOBE NEWSWIRE) — Denny’s Corporation (NASDAQ: DENN) (“Denny’s” or the “Company”), franchisor and operator of one of America’s largest franchised full-service restaurant chains, today announced that it has priced its underwritten public offering of 8,000,000 shares of its common stock, $0.01 par value (“Common Stock”), at a public offering price of $9.15 per share of Common Stock.  In addition, Denny’s granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock.  The offering is expected to close on July 6, 2020, subject to customary closing conditions.Denny’s expects to receive net proceeds of approximately $69.6 million (or approximately $80.1 million if the underwriters exercise in full their option to purchase additional shares of Common Stock) in...

In an ongoing U.S. Phase 1/2 placebo-controlled, observer-blinded clinical trial, nucleoside-modified messenger RNA vaccine candidate (BNT162b1) expressing the SARS-CoV-2 receptor binding domain (RBD) is being evaluated in 45 subjectsAt day 28 (7 days after dose 2), all subjects who received 10 µg or 30 µg of BNT162b1 had significantly elevated RBD-binding IgG antibodies with geometric mean concentrations (GMCs) of 4,813 units/ml and 27,872 units/ml which are 8- and 46.3-times, respectively, the GMC of 602 units/ml in a panel of 38 sera of convalescent patients who had contracted SARS-CoV-2At day 28 (7 days after dose 2), all subjects who received 10 µg or 30 µg of BNT162b1 had SARS-CoV-2 neutralizing antibodies with geometric mean titers (GMTs) of 168 and 267, which are 1.8- and 2.8-times, respectively, the GMT of the convalescent serum...

In der laufenden verblindeten, Placebo-kontrollierten Phase-1/2-Studie in den USA wird ein nukleosidmodifizierter messenger-RNA-Impfstoffkandidat (BNT162b1), der für die Rezeptorbindungsdomäne (RBD) von SARS-CoV-2 codiert, in 45 Probanden getestet.In allen Probanden, die 10 µg bzw. 30 µg BNT162b1 erhalten haben, wurde an Tag 28 (7 Tage nach der zweiten Impfung) eine signifikante Erhöhung der RBD-bindenden IgG-Antikörper festgestellt. Der jeweilige geometrische Mittelwert der Antikörper-Konzentrationen (GMC, Geometric Mean Concentration) betrug 4,813 units/ml bzw. 27,872 units/ml – dies entspricht einer 8-fachen bzw. 46,3-fachen Erhöhung verglichen mit dem GMC von 602 units/ml in Rekonvaleszenz-Seren von 38 Patienten, die von einer SARS-CoV-2-Infektion genesen sind.In allen Probanden, die 10 µg bzw. 30 µg BNT162b1 erhalten haben, wurden...

NEW YORK, July 01, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) will host a conference call on Tuesday, July 28, 2020 at 9:00 AM ET to discuss the Company’s financial results for the second quarter of 2020.The conference call will be broadcast live via this link on the Investor Relations section of Cowen’s website. Please access the link at least 15 minutes prior to the call to register. A replay will be available on the Investor Relations section of Cowen’s website approximately two hours after completion of the conference call at investor.cowen.com/events.Investors can also access the conference call by dialing 1-855-760-0961 (1-631-485-4850 outside the U.S.)  The passcode for the call is 5580959. A recording of the conference call will be available for one week beginning at 12:00 PM ET on...